MTOR and Miyoshi myopathy: Accordingly, we hypothesize that E35 can induce apoptosis in MM cells, thus suppressing the activation and phosphorylation of the Akt/mTOR/4EBP1 signaling pathway; moreover, it may present synergistic effects with bortezomib.